Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 3
2007 1
2008 5
2009 6
2010 1
2011 3
2012 8
2013 16
2014 11
2015 8
2016 9
2017 12
2018 20
2019 14
2020 13
2021 16
2022 19
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Targeted therapies in pulmonary arterial hypertension.
Montani D, Chaumais MC, Guignabert C, Günther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Savale L, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Among authors: guignabert c. Pharmacol Ther. 2014 Feb;141(2):172-91. doi: 10.1016/j.pharmthera.2013.10.002. Epub 2013 Oct 14. Pharmacol Ther. 2014. PMID: 24134901 Free article. Review.
Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
Yanagihara T, Tsubouchi K, Zhou Q, Chong M, Otsubo K, Isshiki T, Schupp JC, Sato S, Scallan C, Upagupta C, Revill S, Ayoub A, Chong SG, Dvorkin-Gheva A, Kaminski N, Tikkanen J, Keshavjee S, Paré G, Guignabert C, Ask K, Kolb MRJ. Yanagihara T, et al. Among authors: guignabert c. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1498-1514. doi: 10.1164/rccm.202109-2174OC. Am J Respir Crit Care Med. 2023. PMID: 36917778
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Guignabert C, et al. Circulation. 2023 Jun 13;147(24):1809-1822. doi: 10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. Circulation. 2023. PMID: 37096577
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
Sanges S, Rice L, Tu L, Valenzi E, Cracowski JL, Montani D, Mantero JC, Ternynck C, Marot G, Bujor AM, Hachulla E, Launay D, Humbert M, Guignabert C, Lafyatis R. Sanges S, et al. Among authors: guignabert c. Ann Rheum Dis. 2023 Mar;82(3):365-373. doi: 10.1136/ard-2022-223237. Epub 2022 Dec 5. Ann Rheum Dis. 2023. PMID: 36600187 Free PMC article.
Endothelial cells in pulmonary fibrosis: more than a bystander.
Yanagihara T, Guignabert C, Kolb MRJ. Yanagihara T, et al. Among authors: guignabert c. Eur Respir J. 2023 Jun 8;61(6):2300407. doi: 10.1183/13993003.00407-2023. Print 2023 Jun. Eur Respir J. 2023. PMID: 37290810 No abstract available.
Purinergic Dysfunction in Pulmonary Arterial Hypertension.
Cai Z, Tu L, Guignabert C, Merkus D, Zhou Z. Cai Z, et al. Among authors: guignabert c. J Am Heart Assoc. 2020 Sep 15;9(18):e017404. doi: 10.1161/JAHA.120.017404. Epub 2020 Sep 1. J Am Heart Assoc. 2020. PMID: 32867554 Free PMC article. Review.
Pathology and Pathobiology of Pulmonary Hypertension.
Guignabert C, Dorfmüller P. Guignabert C, et al. Semin Respir Crit Care Med. 2017 Oct;38(5):571-584. doi: 10.1055/s-0037-1606214. Epub 2017 Oct 15. Semin Respir Crit Care Med. 2017. PMID: 29032561 Review. No abstract available.
164 results